Skip to main content
Premium Trial:

Request an Annual Quote

Nanogen Licenses MDx Technology to Swedish Firm

NEW YORK (GenomeWeb News) – Nanogen said today that it has licensed to Scandinavian Gene Synthesis the rights to its MGB Probe technology and synthetic nucleic acid chemistries and dyes and quenchers.

Under the licensing deal, SGS has the right to use its own cGMP manufacturing capabilities to make and sell molecular diagnostic products incorporating Nanogen's technology. In return, Nanogen will receive an upfront license fee and a commitment for Nanogen to supply component products for use by SGS in designing and manufacturing custom DNA oligonucleotides for the molecular diagnostics market.

Further terms of the pact were not disclosed.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.